16 research outputs found
MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women
The gene MTNR1B encodes a receptor for melatonin. Melatonin receptors are expressed in human -cells, which implies that genetic variants might affect glucose tolerance. Meta-analysis confirmed that the rs10830963 shows the most robust association. The aim of the study was to assess the rs10830963 in Czech GDM patients and controls and to study relations between the SNP and biochemical as well as anthropometric characteristics. Our cohort consisted of 880 women; 458 were diagnosed with GDM, and 422 were normoglycemic controls without history of GDM. Despite similar BMI, the GDM group showed higher WHR, waist circumference, abdominal circumference, and total body fat content. The risk allele G was more frequent in the GDM group (38.3 versus 29.4% in controls, OR 1.49 CI95% [1.22; 1.82]; OR = 0.0001). In spite of higher frequency, the G allele in the GDM group was not associated with any markers of glucose metabolism. In contrast, controls showed significant association of the allele G with FPG and with postchallenge glycemia during the oGTT. Frequency analysis indicates that rs10830963 is involved in gestational diabetes in Czech women. However, the association of the SNP with glucose metabolism, which is obvious in controls, is covert in women who have experienced GDM
MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women
The gene MTNR1B encodes a receptor for melatonin. Melatonin receptors are expressed in human β-cells, which implies that genetic variants might affect glucose tolerance. Meta-analysis confirmed that the rs10830963 shows the most robust association. The aim of the study was to assess the rs10830963 in Czech GDM patients and controls and to study relations between the SNP and biochemical as well as anthropometric characteristics. Our cohort consisted of 880 women; 458 were diagnosed with GDM, and 422 were normoglycemic controls without history of GDM. Despite similar BMI, the GDM group showed higher WHR, waist circumference, abdominal circumference, and total body fat content. The risk allele G was more frequent in the GDM group (38.3 versus 29.4% in controls, OR 1.49 CI95% [1.22; 1.82]; POR=0.0001). In spite of higher frequency, the G allele in the GDM group was not associated with any markers of glucose metabolism. In contrast, controls showed significant association of the allele G with FPG and with postchallenge glycemia during the oGTT. Frequency analysis indicates that rs10830963 is involved in gestational diabetes in Czech women. However, the association of the SNP with glucose metabolism, which is obvious in controls, is covert in women who have experienced GDM
Insulin sensitivity and secretion in obese Type 2 diabetic women after various bariatric operations
Objective: To compare the effects of biliopancreatic diversion (BPD) and laparoscopic gastric banding (LAGB) on insulin sensitivity and secretion with the effects of laparoscopic gastric plication (P). Methods: A total of 52 obese women (age 30-66 years) suffering from type 2 diabetes mellitus (T2DM) were prospectively recruited into three study groups: 16 BPD; 16 LAGB, and 20 P. Euglycemic clamps and mixed meal tolerance tests were performed before, at 1 month and at 6 months after bariatric surgery. Beta cell function derived from the meal test parameters was evaluated using mathematical modeling. Results: Glucose disposal per kilogram of fat free mass (a marker of peripheral insulin sensitivity) increased significantly in all groups, especially after 1 month. Basal insulin secretion decreased significantly after all three types of operations, with the most marked decrease after BPD compared with P and LAGB. Total insulin secretion decreased significantly only following the BPD. Beta cell glucose sensitivity did not change significantly post-surgery in any of the study groups. Conclusion: We documented similar improvement in insulin sensitivity in obese T2DM women after all three study operations during the 6-month postoperative follow-up. Notably, only BPD led to decreased demand on beta cells (decreased integrated insulin secretion), but without increasing the beta cell glucose sensitivity
Chondrosarcomas of the small bones: analysis of 44 patients
BackgroundChondrosarcomas of the small bones of the hands and feet are
uncommon and account for less than 2% of all chondrosarcomas in the
skeleton; a 4.2% rate of malignant degeneration of enchondromas to
secondary chondrosarcomas has been reported. We performed this study to
assess the outcome of the patients with chondrosarcomas of the small
bones. We hypothesized that the presumed better prognosis of
chondrosarcomas in these locations could be biased as the majority of
these tumors tend to be of lower grades and are removed when still small
sized, and that less aggressive surgery has an adverse effect on local
controlMaterials and methodsWe retrospectively studied the files of 44
patients with chondrosarcomas of the small bones of the hands and feet.
There were 23 female and 21 male patients with a mean age of 50.9 years
(range, 6-86 years). The mean follow-up was 13 years (range, 5-40
years). We recorded the patients’ details including gender and age at
diagnosis, type and duration of symptoms, tumor location and histology,
type of surgery and complications, and outcome (local recurrences and
metastases).ResultsThe most common anatomical location for
chondrosarcomas of the hands was the metacarpals and proximal phalanges.
The most common presenting symptom was a slowly enlarging palpable mass.
Overall, 36 chondrosarcomas were secondary to a pre-existing
cartilaginous tumor. Patients with syndromes were affected in younger
age compared to the others. The mean age at diagnosis was higher for
higher grade chondrosarcomas. Overall, 13 patients (29.5%) experienced
a local recurrence; the rate of local recurrence was higher after
curettage regardless the histological grade of the tumors. After wide
resection of the first local recurrence, five patients experienced local
re-recurrence. Five patients (11.4%) experienced lung metastases, two
patients at presentation. All these patients had a high grade
chondrosarcomas. At the last follow-up, one patient with lung metastases
died from disease, and another patient died from unrelated
cause.ConclusionsThe patients with chondrosarcomas of the small bones of
the hands and feet may have a dismal outcome if treated improperly. A
careful treatment planning is required to avoid unnecessary amputations.
Curettage is associated with a high rate for local recurrence that
should be treated with a more aggressive surgical resection to avoid
re-recurrences. Although the risk is low, the patients may develop lung
metastases, especially those with higher grade chondrosarcomas,
therefore, they should be staged and followed closely
<i>RET</i> Variants and Haplotype Analysis in a Cohort of Czech Patients with Hirschsprung Disease
<div><p>Hirschsprung disease (HSCR) is a congenital aganglionosis of myenteric and submucosal plexuses in variable length of the intestine. This study investigated the influence and a possible modifying function of <i>RET</i> proto-oncogene's single nucleotide polymorphisms (SNPs) and haplotypes in the development and phenotype of the disease in Czech patients. Genotyping of 14 SNPs was performed using TaqMan Genotyping Assays and direct sequencing. The frequencies of SNPs and generated haplotypes were statistically evaluated using chi-square test and the association with the risk of HSCR was estimated by odds ratio. SNP analysis revealed significant differences in frequencies of 11 polymorphic <i>RET</i> variants between 162 HSCR patients and 205 unaffected controls. Particularly variant alleles of rs1864410, rs2435357, rs2506004 (intron 1), rs1800858 (exon 2), rs1800861 (exon 13), and rs2565200 (intron 19) were strongly associated with increased risk of HSCR (p<0.00000) and were over-represented in males vs. females. Conversely, variant alleles of rs1800860, rs1799939 and rs1800863 (exons 7, 11, 15) had a protective role. The haploblock comprising variants in intron 1 and exon 2 was constructed. It represented a high risk of HSCR, however, the influence of other variants was also found after pruning from effect of this haploblock. Clustering patients according to genotype status in haploblock revealed a strong co-segregation with several SNPs and pointed out the differences between long and short form of HSCR. This study involved a large number of SNPs along the entire <i>RET</i> proto-oncogene with demonstration of their risk/protective role also in haplotype and diplotype analysis in the Czech population. The influence of some variant alleles on the aggressiveness of the disease and their role in gender manifestation differences was found. These data contribute to worldwide knowledge of the genetics of HSCR.</p></div
Haplotype blocks generated by the Haploview Programme in cohorts of HSCR patients and control population.
<p>The scheme is shown with confidence bounds. LD values are reported in D′.</p
Distribution of haplotypes and diplotypes of 5′ region haploblock in HSCR patients and controls.
<p>* Haplotypes/diplotypes with occurrence <2% in both cohorts are not included.</p
Allelic distribution of single nucleotide polymorphisms in HSCR patients and controls.
<p>Allelic distribution of single nucleotide polymorphisms in HSCR patients and controls.</p
Thyroid Cancer Detection in a Routine Clinical Setting: Performance of ACR TI-RADS, FNAC, and Molecular Testing in Prospective Cohort Study
The aim of our study was to address the potential for improvements in thyroid cancer detection in routine clinical settings using a clinical examination, the American College of Radiology Thyroid Imaging Reporting and Database System (ACR TI-RADS), and fine-needle aspiration cytology (FNAC) concurrently with molecular diagnostics. A prospective cohort study was performed on 178 patients. DNA from FNA samples was used for next-generation sequencing to identify mutations in the genes BRAF, HRAS, KRAS, NRAS, and TERT. RNA was used for real-time PCR to detect fusion genes. The strongest relevant positive predictors for malignancy were the presence of genetic mutations (p p p < 0.01). Overall, FNAC, ACR TI-RADS, and genetic testing reached a sensitivity of up to 96.1% and a specificity of 88.3%, with a diagnostic odds ratio (DOR) of 183.6. Sensitivity, specificity, and DOR decreased to 75.0%, 88.9%, and 24.0, respectively, for indeterminate (Bethesda III, IV) FNAC results. FNA molecular testing has substantial potential for thyroid malignancy detection and could lead to improvements in our approaches to patients. However, clinical examination, ACR TI-RADS, and FNAC remained relevant factors
Allelic distribution of single nucleotide polymorphisms of 5′ region haploblock in patients with long-segment and short-segment form of HSCR and in male and female HSCR patients.
<p>Allelic distribution of single nucleotide polymorphisms of 5′ region haploblock in patients with long-segment and short-segment form of HSCR and in male and female HSCR patients.</p